244 related articles for article (PubMed ID: 21454630)
21. (1)H-MRS in glutaric aciduria type 1: impact of biochemical phenotype and age on the cerebral accumulation of neurotoxic metabolites.
Harting I; Boy N; Heringer J; Seitz A; Bendszus M; Pouwels PJ; Kölker S
J Inherit Metab Dis; 2015 Sep; 38(5):829-38. PubMed ID: 25860816
[TBL] [Abstract][Full Text] [Related]
22. Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement.
Mateu-Bosch A; Segur-Bailach E; García-Villoria J; Gea-Sorlí S; Ruiz I; Del Rey J; Camps J; Guitart-Mampel M; Garrabou G; Tort F; Ribes A; Fillat C
Gene Ther; 2024 Jan; 31(1-2):12-18. PubMed ID: 37985879
[TBL] [Abstract][Full Text] [Related]
23. A role of astrocytes in mediating postnatal neurodegeneration in Glutaric acidemia-type 1.
Olivera-Bravo S; Barbeito L
FEBS Lett; 2015 Nov; 589(22):3492-7. PubMed ID: 26409499
[TBL] [Abstract][Full Text] [Related]
24. Reduction of Na+, K+-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: a possible mechanism for brain injury in glutaric aciduria type I.
Amaral AU; Seminotti B; Cecatto C; Fernandes CG; Busanello EN; Zanatta Â; Kist LW; Bogo MR; de Souza DO; Woontner M; Goodman S; Koeller DM; Wajner M
Mol Genet Metab; 2012 Nov; 107(3):375-82. PubMed ID: 22999741
[TBL] [Abstract][Full Text] [Related]
25. Higher Vulnerability of Menadione-Exposed Cortical Astrocytes of Glutaryl-CoA Dehydrogenase Deficient Mice to Oxidative Stress, Mitochondrial Dysfunction, and Cell Death: Implications for the Neurodegeneration in Glutaric Aciduria Type I.
Rodrigues MDN; Seminotti B; Zanatta Â; de Mello Gonçalves A; Bellaver B; Amaral AU; Quincozes-Santos A; Goodman SI; Woontner M; Souza DO; Wajner M
Mol Neurobiol; 2017 Aug; 54(6):4795-4805. PubMed ID: 27510504
[TBL] [Abstract][Full Text] [Related]
26. Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.
Amaral AU; Cecatto C; Seminotti B; Zanatta Â; Fernandes CG; Busanello EN; Braga LM; Ribeiro CA; de Souza DO; Woontner M; Koeller DM; Goodman S; Wajner M
Mol Genet Metab; 2012 Sep; 107(1-2):81-6. PubMed ID: 22578804
[TBL] [Abstract][Full Text] [Related]
27. Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Amaral AU; Cecatto C; Seminotti B; Ribeiro CA; Lagranha VL; Pereira CC; de Oliveira FH; de Souza DG; Goodman S; Woontner M; Wajner M
Brain Res; 2015 Sep; 1620():116-29. PubMed ID: 25998543
[TBL] [Abstract][Full Text] [Related]
28. The unsolved puzzle of neuropathogenesis in glutaric aciduria type I.
Jafari P; Braissant O; Bonafé L; Ballhausen D
Mol Genet Metab; 2011 Dec; 104(4):425-37. PubMed ID: 21944461
[TBL] [Abstract][Full Text] [Related]
29. Clinical and mutational spectra of 23 Chinese patients with glutaric aciduria type 1.
Wang Q; Li X; Ding Y; Liu Y; Song J; Yang Y
Brain Dev; 2014 Oct; 36(9):813-22. PubMed ID: 24332224
[TBL] [Abstract][Full Text] [Related]
30. Inherited Disorders of Lysine Metabolism: A Review.
Bouchereau J; Schiff M
J Nutr; 2020 Oct; 150(Suppl 1):2556S-2560S. PubMed ID: 33000154
[TBL] [Abstract][Full Text] [Related]
31. Interaction of glutaric aciduria type 1-related glutaryl-CoA dehydrogenase with mitochondrial matrix proteins.
Schmiesing J; Schlüter H; Ullrich K; Braulke T; Mühlhausen C
PLoS One; 2014; 9(2):e87715. PubMed ID: 24498361
[TBL] [Abstract][Full Text] [Related]
32. Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH).
Keyser B; Mühlhausen C; Dickmanns A; Christensen E; Muschol N; Ullrich K; Braulke T
Hum Mol Genet; 2008 Dec; 17(24):3854-63. PubMed ID: 18775954
[TBL] [Abstract][Full Text] [Related]
33. Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I.
Herskovitz M; Goldsher D; Sela BA; Mandel H
Neurology; 2013 Aug; 81(9):849-50. PubMed ID: 23884036
[TBL] [Abstract][Full Text] [Related]
34. A Korean patient with glutaric aciduria type 1 with a novel mutation in the glutaryl CoA dehydrogenase gene.
Kim HS; Yu HJ; Lee J; Park HD; Kim JH; Shin HJ; Jin DK; Lee M
Ann Clin Lab Sci; 2014; 44(2):213-6. PubMed ID: 24795062
[TBL] [Abstract][Full Text] [Related]
35. l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.
Guerreiro G; Amaral AU; Ribeiro RT; Faverzani J; Groehs AC; Sitta A; Deon M; Wajner M; Vargas CR
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2420-2427. PubMed ID: 31181292
[TBL] [Abstract][Full Text] [Related]
36. Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons.
Yodoya E; Wada M; Shimada A; Katsukawa H; Okada N; Yamamoto A; Ganapathy V; Fujita T
J Neurochem; 2006 Apr; 97(1):162-73. PubMed ID: 16524379
[TBL] [Abstract][Full Text] [Related]
37. Disease-causing mutations affecting surface residues of mitochondrial glutaryl-CoA dehydrogenase impair stability, heteromeric complex formation and mitochondria architecture.
Schmiesing J; Lohmöller B; Schweizer M; Tidow H; Gersting SW; Muntau AC; Braulke T; Mühlhausen C
Hum Mol Genet; 2017 Feb; 26(3):538-551. PubMed ID: 28062662
[TBL] [Abstract][Full Text] [Related]
38. Prenatal diagnosis of fetal glutaric aciduria type 1 with rare compound heterozygous mutations in GCDH gene.
Peng HH; Shaw SW; Huang KG
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):137-140. PubMed ID: 29458885
[TBL] [Abstract][Full Text] [Related]
39. Ammonium accumulation and chemokine decrease in culture media of Gcdh
Cudré-Cung HP; Remacle N; do Vale-Pereira S; Gonzalez M; Henry H; Ivanisevic J; Schmiesing J; Mühlhausen C; Braissant O; Ballhausen D
Mol Genet Metab; 2019 Apr; 126(4):416-428. PubMed ID: 30686684
[TBL] [Abstract][Full Text] [Related]
40. Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.
Sauer SW; Okun JG; Fricker G; Mahringer A; Müller I; Crnic LR; Mühlhausen C; Hoffmann GF; Hörster F; Goodman SI; Harding CO; Koeller DM; Kölker S
J Neurochem; 2006 May; 97(3):899-910. PubMed ID: 16573641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
